Cognitive deterioration upon admission is an important risk indicator of falls in the respiratory ward, Masafumi Nojiri, Tatsuya Watanabe, Koichi Yamamura, Saki Matsuura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Ryo Kato, Shohei Shinomiya, Yutaka Takahara, Yuki Fujimoto, Taku Oikawa, Shiro Mizuno, Physical Medicine and Rehabilitation Resarch, 5:1-5, Aug. 2020
A case of ROS1-rearranged lung adenocarcinoma with osteoblastic bone metastasis, Takahara Yutaka, Yamamura Kouichi, Matsuura Saki, Sakuma Takashi, Nishiki Kazuaki, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Oikawa Rieko, Fujimoto Yuki, Oikawa Taku, Osanai Kazuhiro, Ueda Yoshimichi, Mizuno Shiro, Respiratory Medicine Case Reports, 30:101124, Jun. 2020
Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows., Takahara Yutaka, Tanaka Takuya, Ishige Yoko, Shionoya Ikuyo, Yamamura Kouichi, Sakuma Takashi, Nishiki Kazuaki, Nakase Keisuke, Nojiri Masafumi, Kato Ryo, Shinomiya Shohei, Fujimoto Yuki, Oikawa Taku, Mizuno Shiro, Thoracic cancer, 12:2758-2766, Oct. 2021
First case of lung cancer with pneumoconiosis and endobronchial leiomyoma complicating the diagnosis., Takahara Yutaka, Yamamura Kouichi, Motono Nozomu, Oikawa Taku, Uramoto Hidetaka, Mizuno Shiro, BMC pulmonary medicine, 21:286-292, Sep. 2021
Early recurrence factors in patients with stage Ⅲ non-small cell lung cancer treated with concurrent chemoradiotherapy, Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno, Thorac Cancer, 13:3451-3458, Dec. 2022
Differential response in patients with large cell neuroendocrine carcinoma of the lung to initial therapy: A case series, Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Taku Oikawa, Shiro Mizuno, Cancer Reports(Hoboken,NJ), e1754:1-8, Nov. 2022
Efficacy and predictors of rechallenge with immune checkpoint inhibitors in non-small cell lung cancer, Yutaka Takahara, Takuya Tanaka, Yoko Ishige, Ikuyo Shionoya, Kouichi Yamamura, Takashi Sakuma, Kazuaki Nishiki, Keisuke Nakase, Masafumi Nojiri, Ryo Kato, Shohei Shinomiya, Yuki Fujimoto, Taku Oikawa, Shiro Mizuno, Thorac Cancer, 13:624-630, Feb. 2022
Serum Derivatives of Reactive Oxygen Metabolites are Associated with Severity of Chronic Obstructive Pulmonary Disease and Affected by a P53 Gene Polymorphism, Koichi Yamamura, Masafumi Nojiri, Kazuaki Nishiki, Ryo Kato, Shohei Shinomiya, Yutaka Takahara, Taku Oikawa, Takeshi Iahizaki, Hirohisa Toga, Shiro Mizuno, International Journal of Chronic Obstructive Pulmonary Disease, 17:1589-1600, Jul. 2022
